Somatropin biosimilar - Sandoz

Drug Profile

Somatropin biosimilar - Sandoz

Alternative Names: Omnitrope; PrOmnitrope

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sandoz
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Growth disorders; Prader-Willi syndrome; Short stature; Somatotropin deficiency; Turner's syndrome
  • Registered Dwarfism

Most Recent Events

  • 02 Sep 2015 Launched for Short stature (In adolescents, In children) in Canada (Parenteral)
  • 02 Sep 2015 Launched for Turner's syndrome (In adolescents, In children) in Canada (Parenteral)
  • 16 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top